腹横肌平面阻滞在显微乳房再造中的应用:疼痛、麻醉药用量、住院时间与费用分析
该研究回顾2015至2017年接受腹部皮瓣显微血管乳房再造的患者,比较使用与未使用布比卡因脂质体腹横肌平面阻滞者的住院时间、并发症、麻醉药用量、供区疼痛及住院费用。阻滞组口服及总麻醉药用量显著减少,供区疼痛显著减轻,住院费用无显著差异;体重指数≥25 kg/m²者阻滞组住院时间显著缩短。
要点
- 布比卡因脂质体腹横肌平面阻滞可显著减少口服及总麻醉药用量并减轻供区疼痛。
- 阻滞组与未阻滞组住院费用无显著差异。
- 体重指数≥25 kg/m²者阻滞组住院时间显著缩短,体重指数<25 kg/m²者无显著差异。
核心结论
- 布比卡因脂质体腹横肌平面阻滞可显著减少腹部皮瓣显微血管乳房再造术后口服及总麻醉药用量和供区疼痛,且不增加住院费用。
- 该阻滞还可显著缩短体重指数≥25 kg/m²患者的住院时间。
研究设计与样本
- 回顾性分析2015年至2017年接受腹部皮瓣显微血管乳房再造的患者,比较使用与未使用布比卡因脂质体腹横肌平面阻滞者的结局。
主要发现
- 50例(43.9%)接受阻滞,其中27例(54.0%)在超声引导下进行;64例(56.1%)未接受阻滞。
- 阻滞组口服麻醉药用量和总麻醉药用量均显著减少(分别为p=0.0001和p<0.0001)。
- 阻滞组供区疼痛显著低于未阻滞组(3.3 vs 4.3;p<0.0001)。
- 两组住院费用无显著差异(每例患者21,531.53美元 vs 22,050.15美元;p=0.5659)。
- 体重指数≥25 kg/m²者中,阻滞组住院时间显著短于未阻滞组(3.8天 vs 4.4天;p=0.0345),且麻醉药用量和术后疼痛也降低。
关键数值与推荐
- 证据等级:治疗性,III级。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transversus abdominis plane blocks are increasingly being used in microvascular breast reconstruction. The implications of these blocks on specific reconstructive, patient, and institutional outcomes remain to be fully elucidated. METHODS: Patients undergoing abdominally based microvascular breast reconstruction from 2015 to 2017 were reviewed. Length of stay, complications, narcotic consumption, donor-site pain, and hospital expenses were compared between patients who did and did not receive transversus abdominis plane blocks with liposomal bupivacaine. Outcomes were subsequently compared in patients with elevated body mass index. RESULTS: Fifty patients (43.9 percent) received blocks [27 (54.0 percent) under ultrasound guidance] and 64 patients (56.1 percent) did not. Patients with the blocks had significantly decreased oral and total narcotic consumption (p = 0.0001 and p < 0.0001, respectively) and significantly less donor-site pain (3.3 versus 4.3; p < 0.0001). There was no significant difference in hospital expenses between the two cohorts ($21,531.53 versus $22,050.15 per patient; p = 0.5659). Patients with a body mass index of 25 kg/m(2) or greater who received a block had a significantly decreased length of stay (3.8 days versus 4.4 days; p = 0.0345) and decreased narcotic consumption and postoperative pain compared with patients without blocks. Patients with a body mass index less than 25 kg/m(2) did not have a significant difference in postoperative pain, narcotic consumption, or length of stay between groups. CONCLUSIONS: Transversus abdominis plane blocks with liposomal bupivacaine significantly reduce oral and total postoperative narcotic consumption and donor-site pain in all patients after abdominally based microvascular breast reconstruction without increasing hospital expenses. The blocks also significantly decrease length of stay in patients with a body mass index greater than or equal to 25 kg/m(2). CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Salibian AA, Frey JD, Thanik VD, et al. Transversus Abdominis Plane Blocks in Microsurgical Breast Reconstruction: Analysis of Pain, Narcotic Consumption, Length of Stay, and Cost. Plast Reconstr Surg. 2018. PMID: 29879000. doi:10.1097/PRS.0000000000004632
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。